Unità di Genetica Medica, Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli, 89124 Reggio Calabria, Italy.
Genetica Molecolare e Genomica Funzionale, Ospedale Pediatrico Bambino Gesù, IRCCS, 00146 Rome, Italy.
Int J Environ Res Public Health. 2023 Mar 4;20(5):4573. doi: 10.3390/ijerph20054573.
Reaching a diagnosis and its communication are two of the most meaningful events in the physician-patient relationship. When facing a disease, most of the patients' expectations rely on the hope that their clinicians would be able to understand the cause of their illness and eventually end it. Rare diseases are a peculiar subset of conditions in which the search for a diagnosis might reveal a long and painful journey scattered by doubts and requiring, in most cases, a long waiting time. For many individuals affected by a rare disease, turning to research might represent their last chance to obtain an answer to their questions. Time is the worst enemy, threatening to disrupt the fragile balance among affected individuals, their referring physicians, and researchers. It is consuming at all levels, draining economic, emotional, and social resources, and triggering unpredictable reactions in each stakeholder group. Managing waiting time is one of the most burdensome tasks for all the parties playing a role in the search for a diagnosis: the patients and their referring physicians urge to obtain a diagnosis in order to know the condition they are dealing with and establish proper management, respectively. On the other hand, researchers need to be objective and scientifically act to give a rigorous answer to their demands. While moving towards the same goal, patients, clinicians, and researchers might have different expectations and perceive the same waiting time as differently hard or tolerable. The lack of information on mutual needs and the absence of effective communication among the parties are the most common mechanisms of the failure of the therapeutic alliance that risk compromising the common goal of a proper diagnosis. In the landscape of modern medicine that goes faster and claims high standards of cure, rare diseases represent an exception where physicians and researchers should learn to cope with time in order to care for patients.
做出诊断及其沟通是医患关系中最有意义的两个事件。当面对疾病时,大多数患者的期望都寄托于临床医生能够理解其疾病的病因并最终治愈。罕见病是一种特殊的病症,在这种疾病中,寻找诊断可能会揭示出一个漫长而痛苦的旅程,充满了疑虑,并需要在大多数情况下长时间等待。对于许多受罕见病影响的人来说,转向研究可能是他们获得问题答案的最后机会。时间是最糟糕的敌人,威胁着破坏受影响个体、他们的转诊医生和研究人员之间脆弱的平衡。它在各个层面上消耗资源,耗尽经济、情感和社会资源,并在每个利益相关者群体中引发不可预测的反应。管理等待时间是所有参与诊断搜索的各方中最繁重的任务之一:患者及其转诊医生都渴望获得诊断,以便了解他们正在处理的病情并进行适当的管理。另一方面,研究人员需要客观和科学地行动,为他们的需求提供严谨的答案。尽管各方都朝着相同的目标前进,但患者、临床医生和研究人员可能会有不同的期望,并认为相同的等待时间是不同程度的困难或难以忍受。缺乏关于相互需求的信息以及各方之间缺乏有效的沟通是治疗联盟失败的最常见机制,这可能会危及适当诊断的共同目标。在现代医学的快速发展和高治愈标准的背景下,罕见病是一个例外,医生和研究人员应该学会应对时间,以关爱患者。